Abstract
Unbiased binding assays involving small-molecule microarrays were used to identify compounds that display unique patterns of selectivity among members of the zinc-dependent histone deacetylase family of enzymes. A novel, hydroxyquinoline-containing compound, BRD4354, was shown to preferentially inhibit activity of HDAC5 and HDAC9 in vitro. Inhibition of deacetylase activity appears to be time-dependent and reversible. Mechanistic studies suggest that the compound undergoes zinc-catalyzed decomposition to an ortho-quinone methide, which covalently modifies nucleophilic cysteines within the proteins. The covalent nature of the compound-enzyme interaction has been demonstrated in experiments with biotinylated probe compound and with electrospray ionization-mass spectrometry.
Original language | English (US) |
---|---|
Pages (from-to) | 1844-1851 |
Number of pages | 8 |
Journal | ACS Chemical Biology |
Volume | 11 |
Issue number | 7 |
DOIs | |
State | Published - Jul 15 2016 |
ASJC Scopus subject areas
- Biochemistry
- Molecular Medicine